Alterity Therapeutics (ATHE) Change in Accured Expenses (2016 - 2020)
Alterity Therapeutics (ATHE) posted quarterly Change in Accured Expenses of -$1033.6 for Q2 2020, up 97.85% quarter-over-quarter from -$48058.2 in Q4 2019.
Alterity Therapeutics (ATHE) Change in Accured Expenses (2016 - 2020) Analysis & Trends
Alterity Therapeutics' Change in Accured Expenses history runs 3 years deep, the most recent figure standing at -$1033.6 for Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 212.44 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 61.62 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 68.82 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -1,033.60 |
| Jun 30, 2020 | -1,033.60 |
| Dec 31, 2019 | -48,058.24 |
| Dec 31, 2019 | -48,058.24 |
| Jun 30, 2016 | -9,017.18 |
| Jun 30, 2016 | -9,017.18 |